228. 閉塞性細気管支炎 Bronchiolitis obliterans Clinical trials / Disease details


臨床試験数 : 97 薬物数 : 118 - (DrugBank : 32) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 156

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00141726
(ClinicalTrials.gov)
October 200330/8/2005Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell TransplantSoluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation. A Phase II StudyLung Injury, Acute;Respiratory Distress Syndrome, Adult;Bronchiolitis ObliteransDrug: EtanerceptUniversity of Michigan Cancer CenterNULLCompleted6 YearsN/AAll34Phase 2United States
2NCT00029328
(ClinicalTrials.gov)
September 200110/1/2002Etanercept for Non-Infectious Lung Injury Following Bone Marrow TransplantationSoluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Acute Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell TransplantationRespiratory Distress Syndrome, Adult;Bronchiolitis Obliterans;PneumoniaDrug: etanerceptFDA Office of Orphan Products DevelopmentNULLCompleted12 MonthsN/ABoth15Phase 1/Phase 2United States